For: | Leoni S, Casabianca A, Biagioni B, Serio I. Viral hepatitis: Innovations and expectations. World J Gastroenterol 2022; 28(5): 517-531 [PMID: 35316960 DOI: 10.3748/wjg.v28.i5.517] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v28/i5/517.htm |
Number | Citing Articles |
1 |
Mamun Al Mahtab, Sheikh Mohammad Fazle Akbar, Julio Cesar Aguilar, Osamu Yoshida, Sakirul Khan, Guillen Nieto Gerardo, Yoichi Hiasa. Safety profile, antiviral capacity, and liver protection of a nasal therapeutic vaccine in patients with chronic hepatitis B: Five-year-follow-up outcomes after the end of treatment. Frontiers in Medicine 2023; 10 doi: 10.3389/fmed.2023.1032531
|
2 |
Qinglin Li, Shengkui Zhang, Miao Yu, Lihua Wang, Zhende Wang, Xiaohong Zhang, Yongbin Wang, Juxiang Yuan. Rotating night shift work and liver enzymes-associated abnormalities among steelworkers: a cross-sectional study from a Chinese cohort. International Archives of Occupational and Environmental Health 2022; 95(10): 1935 doi: 10.1007/s00420-022-01894-0
|
3 |
Long-Bao Yang, Xin Gao, Hong Li, Xin-Xing Tantai, Fen-Rong Chen, Lei Dong, Xu-Sheng Dang, Zhong-Cao Wei, Chen-Yu Liu, Yan Wang. Non-invasive model for predicting high-risk esophageal varices based on liver and spleen stiffness. World Journal of Gastroenterology 2023; 29(25): 4072-4084 doi: 10.3748/wjg.v29.i25.4072
Abstract(634) |
Core Tip(540) |
Full Article(HTML)(2364)
|
Full Article with Cover (PDF)-2049K(79)
|
Full Article (Word)-364K(47)
|
Audio-1783K(2)
|
Peer-Review Report-197K(88)
|
Answering Reviewers-143K(53)
|
Full Article (PDF)-795K(185)
|
Full Article (XML)-135K(58)
|
Times Cited (7)
|
Total Visits (6657)
|
Open
|
4 |
Qiumin Luo, Jia Chen, Yeqiong Zhang, Wenxiong Xu, Ying Liu, Chan Xie, Liang Peng. Viral hepatitis E: Clinical manifestations, treatment, and prevention. Liver Research 2024; 8(1): 11 doi: 10.1016/j.livres.2024.01.001
|
5 |
Yijuan Chen, Jian Gao, Wanwan Sun, Weiping Zhu, Pingping Wang, Xiaobin Ren, Yumeng Wu, Jianli Zhang, Ziping Miao. Clinical characteristics and risk factors of Hepatitis E virus infection in Zhejiang Province: a multicenter case–control study. Frontiers in Public Health 2024; 12 doi: 10.3389/fpubh.2024.1417556
|
6 |
Junhong Lu, Qingwen Deng, Yuehua Chen, Wenbin Liu. Impact of perceived ease of use, organizational support mechanism, and industry competitive pressure on physicians’ use of liver cancer screening technology in medical alliances. Frontiers in Public Health 2023; 11 doi: 10.3389/fpubh.2023.1174334
|
7 |
Fabiola Di Dato, Raffaele Iorio. Expanding indications for chronic hepatitis B treatment: Is it really desirable to treat everyone?. World Journal of Gastroenterology 2024; 30(17): 2294-2297 doi: 10.3748/wjg.v30.i17.2294
|
8 |
Yongxin Wang, Kai Liu. Therapeutic potential of oleanolic acid in liver diseases. Naunyn-Schmiedeberg's Archives of Pharmacology 2024; 397(7): 4537 doi: 10.1007/s00210-024-02959-2
|
9 |
Akihide Kamiya, Kinuyo Ida. Liver Injury and Cell Survival in Non-Alcoholic Steatohepatitis Regulated by Sex-Based Difference through B Cell Lymphoma 6. Cells 2022; 11(23): 3751 doi: 10.3390/cells11233751
|
10 |
Jijiao Wu, Lin Wen, Xiaolian Liu, Qiuxia Li, Zihao Sun, Chuipeng Liang, Fan Xie, Xiaofang Li. Silybin: A Review of Its Targeted and Novel Agents for Treating Liver Diseases Based on Pathogenesis. Phytotherapy Research 2024; doi: 10.1002/ptr.8347
|
11 |
Ernest C. Agwamba, Hitler Louis, Innocent Benjamin, Chioma G. Apebende, Tomsmith O. Unimuke, Henry O. Edet, Akaninyene Udoikono, Adanna D. Nwagu, Adedapo S. Adeyinka. (E)-2-((3-Nitrophenyl)Diazenyl)-3-Oxo-3-Phenylpropanal: Experimental, DFT Studies, and Molecular Docking Investigations. Chemistry Africa 2022; 5(6): 2131 doi: 10.1007/s42250-022-00468-4
|
12 |
Saba Ahmed, Rosario Yslado Méndez, Shaheryar Naveed, Shoaib Akhter, Iqra Mushtaque, Mareen A. Malik, Waqar Ahmad, Roger Norabuena Figueroa, Ammar Younas. Assessment of hepatitis-related knowledge, attitudes, and practices on quality of life with the moderating role of internalized stigma among hepatitis B-positive patients in Pakistan. Health Psychology and Behavioral Medicine 2023; 11(1) doi: 10.1080/21642850.2023.2192782
|
13 |
Yun-Feng Yu, Gang Hu, Ke-Ke Tong, Xin-Yu Yang, Jing-Yi Wu, Rong Yu. Effect of viral hepatitis on type 2 diabetes: A Mendelian randomization study. World Journal of Diabetes 2024; 15(2): 220-231 doi: 10.4239/wjd.v15.i2.220
Abstract(246) |
Core Tip(345) |
Full Article(HTML)(1592)
|
Full Article with Cover (PDF)-1899K(75)
|
Full Article (Word)-1009K(22)
|
Audio-1806K(1)
|
Peer-Review Report-202K(54)
|
Answering Reviewers-112K(58)
|
Supplementary Material-368K(60)
|
Full Article (PDF)-1562K(126)
|
Full Article (XML)-134K(51)
|
Times Cited (0)
|
Total Visits (4359)
|
Open
|
14 |
Huiqiong Zou, Peipei Hao, Yingying Cao, Li Li, Ruifeng Ding, Xuefeng Bai, Yongzhi Xue. Hippophae rhamnoides reverses decreased CYP2D6 expression in rats with BCG-induced liver injury. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-44590-w
|
15 |
Hongtao Liu, Dariusz Zakrzewicz, Kamil Nosol, Rossitza N. Irobalieva, Somnath Mukherjee, Rose Bang-Sørensen, Nora Goldmann, Sebastian Kunz, Lorenzo Rossi, Anthony A. Kossiakoff, Stephan Urban, Dieter Glebe, Joachim Geyer, Kaspar P. Locher. Structure of antiviral drug bulevirtide bound to hepatitis B and D virus receptor protein NTCP. Nature Communications 2024; 15(1) doi: 10.1038/s41467-024-46706-w
|